Fetal whole genome sequencing as a clinical diagnostic tool: Advantages, limitations and pitfalls

Lina Basel-Salmon*, Dana Brabbing-Goldstein

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Genome-wide sequencing, which includes exome sequencing and genome sequencing, has revolutionized the diagnostics of genetic disorders in both postnatal and prenatal settings. Compared to exome sequencing, genome sequencing enables the detection of many additional types of genomic variants, although this depends on the bioinformatics pipelines used. Variant classification might vary among laboratories. In the prenatal setting, variant classification may change if new fetal phenotypic features emerge as the pregnancy progresses. There is still a need to evaluate the incremental diagnostic yield of genome sequencing compared to exome sequencing in the prenatal setting. This article reviews the advantages and limitations of genome sequencing, with an emphasis on fetal diagnostics.

Original languageEnglish
Article number102549
JournalBest Practice and Research: Clinical Obstetrics and Gynaecology
Volume97
DOIs
StatePublished - Dec 2024

Keywords

  • Case interpretation
  • Diagnostic yield
  • Evolving phenotype
  • Fetal testing
  • Prenatal genome sequencing
  • Variant classification

Fingerprint

Dive into the research topics of 'Fetal whole genome sequencing as a clinical diagnostic tool: Advantages, limitations and pitfalls'. Together they form a unique fingerprint.

Cite this